Literature DB >> 25231618

Adeno-associated virus-RNAi of GlyRα1 and characterization of its synapse-specific inhibition in OFF alpha transient retinal ganglion cells.

C Zhang1, S B Rompani2, B Roska2, M A McCall3.   

Abstract

In the central nervous system, inhibition shapes neuronal excitation. In spinal cord glycinergic inhibition predominates, whereas GABAergic inhibition predominates in the brain. The retina uses GABA and glycine in approximately equal proportions. Glycinergic crossover inhibition, initiated in the On retinal pathway, controls glutamate release from presynaptic OFF cone bipolar cells (CBCs) and directly shapes temporal response properties of OFF retinal ganglion cells (RGCs). In the retina, four glycine receptor (GlyR) α-subunit isoforms are expressed in different sublaminae and their synaptic currents differ in decay kinetics. GlyRα1, expressed in both On and Off sublaminae of the inner plexiform layer, could be the glycinergic isoform that mediates On-to-Off crossover inhibition. However, subunit-selective glycine contributions remain unknown because we lack selective antagonists or cell class-specific subunit knockouts. To examine the role of GlyRα1 in direct inhibition in mature RGCs, we used retrogradely transported adeno-associated virus (AAV) that performed RNAi and eliminated almost all glycinergic spontaneous and visually evoked responses in PV5 (OFFα(Transient)) RGCs. Comparisons of responses in PV5 RGCs infected with AAV-scrambled-short hairpin RNA (shRNA) or AAV-Glra1-shRNA confirm a role for GlyRα1 in crossover inhibition in cone-driven circuits. Our results also define a role for direct GlyRα1 inhibition in setting the resting membrane potential of PV5 RGCs. The absence of GlyRα1 input unmasked a serial and a direct feedforward GABA(A)ergic modulation in PV5 RGCs, reflecting a complex interaction between glycinergic and GABA(A)ergic inhibition.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  AAV-RNAi; glycine receptor; inhibitory circuitry; retinal ganglion cell

Mesh:

Substances:

Year:  2014        PMID: 25231618      PMCID: PMC4269711          DOI: 10.1152/jn.00505.2014

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  57 in total

1.  Surround inhibition of mammalian AII amacrine cells is generated in the proximal retina.

Authors:  S A Bloomfield; D Xin
Journal:  J Physiol       Date:  2000-03-15       Impact factor: 5.182

2.  Distinct expressions of contrast gain control in parallel synaptic pathways converging on a retinal ganglion cell.

Authors:  Deborah Langrill Beaudoin; Michael B Manookin; Jonathan B Demb
Journal:  J Physiol       Date:  2008-10-02       Impact factor: 5.182

Review 3.  Recombinant AAV as a platform for translating the therapeutic potential of RNA interference.

Authors:  Florie Borel; Mark A Kay; Christian Mueller
Journal:  Mol Ther       Date:  2013-12-19       Impact factor: 11.454

4.  Synaptic pathways that shape the excitatory drive in an OFF retinal ganglion cell.

Authors:  Ilya Buldyrev; Theresa Puthussery; W Rowland Taylor
Journal:  J Neurophysiol       Date:  2011-12-28       Impact factor: 2.714

5.  Selective glycine receptor α2 subunit control of crossover inhibition between the on and off retinal pathways.

Authors:  Regina D Nobles; Chi Zhang; Ulrike Müller; Heinrich Betz; Maureen A McCall
Journal:  J Neurosci       Date:  2012-03-07       Impact factor: 6.167

Review 6.  Six different roles for crossover inhibition in the retina: correcting the nonlinearities of synaptic transmission.

Authors:  Frank S Werblin
Journal:  Vis Neurosci       Date:  2010-04-15       Impact factor: 3.241

7.  Receptive field properties of ON- and OFF-ganglion cells in the mouse retina.

Authors:  Michiel van Wyk; Heinz Wässle; W Rowland Taylor
Journal:  Vis Neurosci       Date:  2009-07-14       Impact factor: 3.241

8.  Exploring the retinal connectome.

Authors:  James R Anderson; Bryan W Jones; Carl B Watt; Margaret V Shaw; Jia-Hui Yang; David Demill; James S Lauritzen; Yanhua Lin; Kevin D Rapp; David Mastronarde; Pavel Koshevoy; Bradley Grimm; Tolga Tasdizen; Ross Whitaker; Robert E Marc
Journal:  Mol Vis       Date:  2011-02-03       Impact factor: 2.367

9.  Glycinergic input of small-field amacrine cells in the retinas of wildtype and glycine receptor deficient mice.

Authors:  J Weiss; G A O'Sullivan; L Heinze; H-X Chen; H Betz; H Wässle
Journal:  Mol Cell Neurosci       Date:  2007-08-23       Impact factor: 4.314

10.  Spatial segregation of adaptation and predictive sensitization in retinal ganglion cells.

Authors:  David B Kastner; Stephen A Baccus
Journal:  Neuron       Date:  2013-08-07       Impact factor: 17.173

View more
  5 in total

1.  GlyRα2, not GlyRα3, modulates the receptive field surround of OFF retinal ganglion cells.

Authors:  Chi Zhang; Regina D Nobles; Maureen A McCall
Journal:  Vis Neurosci       Date:  2015       Impact factor: 3.241

2.  Sensitivity to image recurrence across eye-movement-like image transitions through local serial inhibition in the retina.

Authors:  Vidhyasankar Krishnamoorthy; Michael Weick; Tim Gollisch
Journal:  Elife       Date:  2017-02-23       Impact factor: 8.140

3.  Organization and emergence of a mixed GABA-glycine retinal circuit that provides inhibition to mouse ON-sustained alpha retinal ganglion cells.

Authors:  Abhilash Sawant; Briana N Ebbinghaus; Adam Bleckert; Clare Gamlin; Wan-Qing Yu; David Berson; Uwe Rudolph; Raunak Sinha; Mrinalini Hoon
Journal:  Cell Rep       Date:  2021-03-16       Impact factor: 9.423

4.  Mouse retinal ganglion cell signalling is dynamically modulated through parallel anterograde activation of cannabinoid and vanilloid pathways.

Authors:  Andrew O Jo; Jennifer M Noel; Monika Lakk; Oleg Yarishkin; Daniel A Ryskamp; Koji Shibasaki; Maureen A McCall; David Križaj
Journal:  J Physiol       Date:  2017-09-07       Impact factor: 5.182

Review 5.  Defects of the Glycinergic Synapse in Zebrafish.

Authors:  Kazutoyo Ogino; Hiromi Hirata
Journal:  Front Mol Neurosci       Date:  2016-06-29       Impact factor: 5.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.